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ABSTRACT  
Objective: The present study was carried out to analyze the relationship between CYP2E1 genetic polymorphism and the risk of developing 
nasopharyngeal cancer (NPC).  
Methods: The study involved 100 patients with nasopharyngeal carcinoma, compared with 180 healthy controls. Genomic DNA samples were 
assayed for restriction fragment length polymorphisms in the CYP2E1 by PCR amplification followed by digestion with RsaI. The frequency 
comparison between the two groups was determined by the χ(2) test.  
Results: Our results showed that the distribution of CYP2E1-/-allele frequency was found to be significantly different between controls (22 %) and 
cancer cases (26%) along with twice increase of the NPC risk in Algeria (OR=2.2, CI 95% [1.02-2.54]).  
Conclusion: Our results are in line with those found for other populations and subsequent they emphasize the importance of the involvement of 
this gene in the development of the NPC detoxification process, which exhibited more and more strong association with environmental factors. 
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Cancers are among the most important non-communicable diseases that 
impose a major disease burden to the society [1], there are over 100 
different types of cancer [2]. Nasopharyngeal cancer (NPC) is a rare 
cancer in most parts of the world [3] with annual age-standardized 
incidence rates typically below 1 per 100,000 people/year, in both sexes 
[4], but occurs at relatively high rates in some geographic regions and 
among certain ethnic groups with the highest incidence [5]. Intermediate 
incidence (8-12 cases/100,000/y) was reported in the North African 
population [6]. 
The distinct geographical and ethnic distribution of NPC seem to be 
associated with certain environmental and hereditary factors [7]. 
Numerous environmental factors have been associated with risk of 
developing nasopharyngeal carcinoma, including infection with the 
Epstein–Barr virus, occupational exposure to cigarette smoking, and 
various dietary factors [8]. Host factors, including human leukocyte 
antigens and cytochrome P450 2E1 (CYP2E1), have also been 
postulated as an important molecule in nasopharyngeal carcinoma 
development T [8, 9].  
The cytochrome P450 enzymes (CYP) represent a large family of 
proteins involved in the metabolism of drugs and other xenobiotics, 
as well as some endogenous substrates. CYP450 consists of the 
superfamily of hem proteins that catalyze the oxidative metabolism 
of a wide variety of exogenous chemicals including drugs [10]. 
CYP2E1, a member of the cytochrome P-450 superfamily, is involved 
in the metabolic activation of many low molecular weight 
compounds such as N-nitrosamines, aniline, vinyl chloride, and 
urethane [11]. This enzyme is also believed to participate in the 
oxidation of other compounds; like ethanol, to produce reactive free 
radicals that may initiate lipid peroxidation and consequently 
carcinogenesis [12]. N-Nitrosamines presented in tobacco and diet 
are well-recognized as carcinogens, involved in cancer development 
in many body parts, including the esophagus and stomach [13]. 
Functional CYP2E1 gene polymorphisms might, therefore, affect 
susceptibility cancers, for which a role is suspected for etiological 
agents such as N-nitrosamines [14]. Among the known genetic 
polymorphisms in the CYP2E1 detectable by Dra I and Taq I 
digestion are not thought to affect the transcription or the function 
of the enzyme encoded by the gene. In contrast, the RsaI variant 
corresponding to a C-1054T substitution (rs2031920) in the 5'-
flanking region appears to be associated with decreased enzyme 
activity or inaudibility [15]. The CYP2E1 gene is present in the 
population in various polymorphic forms. The variants detectable by 
RsaI digestion (called the variant form and wild-type form). The 
form of variant contains polymorphic base substitution sites in a 
region of the gene that is not transcribed but that appears to be 
involved in the transcriptional regulation of CYP2E1 expression [16, 
17]. However, there has been considered as one in vitro study, 
showing that the variant allele (-/-) increased expression of a 
reporter gene constructs [18].  
In the present study, we examined the relationship between CYP2EI 
genotypes and the risk of developing NPC pathogenesis within 100 
NPC cases and 180 matched healthy controls from Algeria. PCR and 
RFLP methods were used to identify polymorphisms in the gene of 
interest. RsaI restriction enzyme digestions were utilized to detect 
genotypic polymorphisms. The use of this restriction enzyme was 
dictated by previous findings suggesting that the two forms of the gene 
detected by RsaI digestion exhibit widely different levels of expression.  
MATERIALS AND METHODS 
Study of patient populations and genomic DNA preparation 
The present study was conducted on 100 patients with NPC and 180 
controls. All subjects were residents of East region of Algeria. The 
cases were recruited over a period from January; 2012 to December; 
2015 at the Cancer Center of Batna, and were histologically 
confirmed as undifferentiated NPC. Controls were frequency-
matched to the cases depending to age (±2 y), gender, and residence. 
In addition, controls of the present study were required to have no 
previous history of NPC identification. At recruitment, each 
participant was personally interviewed, in order to obtain detailed 
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information on ethnicity and family disease history 
sociodemographic characteristics, recent and prior tobacco use. 
Subjects were afterwards asked to consent to the collection of 
approximately 5 ml blood; the 280 samples were taken with their 
consent and permission. All DNA samples were extracted from 
whole blood collected in K3E (K3EDTA) anticoagulant tubes 
according to the protocol stand by the manufacturer, using the 
wizard genomic DNA kit part ® 050 (PROMEGA, United States of 
America). 
PCR-RFLP analysis  
Genomic DNA (0.1 μg) extracted from whole blood was used for each 
PCR analysis. The amplification was performed with primers as 
described previously by Hayashi et al.1991. The total reaction volume of 
50 μl consisted of 20μM Tris-HCl (pH 8.4), 50 mmol KCl, 1.5 mmol 
MgCl2, 125 μM deoxynucleoside triphosphate, 0.2 μM primers, 4 U Taq 
DNA polymorase (Gibco), and 0.2 μg of template DNA. The method of 
Hayashi et al. [19] was used to identify genotypes of CYP2E1 using Rsal 
digestion. In brief, two primers used were: (a)-5' CCAGTCGAG-
TCTACATTGTCA-3', and (b) 5'-TTCATTCTGTCTTCTAAC-TGG-3', which 
produce 410 bp fragment. The PCR conditions were 40 cycles at 92 °C for 
1 minute, 60 °C for 1 minute, 72 °C for 2 min and final elongation step of 
5 min at 72 °C in a Perkin-Elmer/DNA thermal Cycle 480. Twenty μl of 
each sample was digested with 10 units RsaI at 37 °C overnight. The 
restricted products were analyzed by electrophoresis on 2% agarose gel. 
Bands were visualized with an ultraviolet trans illuminator after 
ethidium bromide staining.  
Statistical analysis 
Pearson’s x2 test was used to examine differences in distributions of 
genotypes studied between cases and controls. ORs with 95% CIs 
calculated using unconditional logistic regression and adjusted for 
age, gender, smoking status, were used to determine the association 
between genotype of the CYP2E1 gene and NPC development. The 
95% confidence interval (CI) was computed to determine the 
statistical significance of the findings. Statistical significance was 
declared if two-sided P<0.05 or if the 95% CI did not include unity. 
All statistical analysis was performed by SPSS (8.0) software. 
RESULTS 
The selected demographic variables of study subjects are 
summarized in table 1. The mean age of the case subjects was 47 y 
(range, 20–more than 60 y); 63% of the case subjects were male. 
Comparable statistics for control subjects were 49 y (range, 20–
more than 60) and 55.5% were male. The majority of our case 
subjects and our control subjects aged between 40 and 60 y. 
Although an effort was made to obtain a frequency match on 
smoking status between cases and controls, more smokers were 
present in the case group compared to controls (p =0.012). No 
family history of esophageal cancer was observed among controls 
and cases. 
This study is based on the analyses of 100 cases with NPC and 
180 normal controls. The DNA fragment of the CYP2E1 gene was 
410bp after PCR amplification with primer RasI. The expected 
sizes of the products after digestion with RasI were as follow: 
homozygous wild-type (+/+) containing restriction site in each 
DNA chain, resulting in electrophoresis bands of 360 bp and 50 
bp; variant homozygote (-/-) without a restriction site and an 
electrophoresis band of 410 bp, and heterozygote (+/-) with 
restriction sites in one of the DNA chains, become into 3 
fragments of 410 bp, 360 bp, and 50 bp. 
 
Table 1: Demographic variable of the study subjects 
 Variable  Control subjects (n = 180)  Cancer cases (n = 100)  
Gender, n (%)   
Male 100 (55.5)  63 (63.0)  
Female 80 (44.4)  37 (37.0)  
Mean age year (range) 49 (20.+60)  47 (20.+60)  
20–40 %  35 (19.44)  20 (20.0)  
40–60 % 97 (53.88)  54 (54.0)  
+60 %  48 (26.66)  26 (26.0)  
Smoking status, n (%)   
Never   115 (63.9)  38 (38.0)  
Current  65 (36.1)  62 (62.0)  
Histologically (%)   
differentiated   25 (25.0)  
undifferentiated   85 (85.0)  
  
The distributions of three CYP2E1 genotypes were then compared 
within carcinoma cases, and controls. As shown in table 2, 11.0% of 
cancer cases were homozygous for the (-/-) allele of CYP2E1; these 
were significantly higher (x2 =30.6; P = 0.0001) than that seen in 
controls (5.0%). Subjects with the homozygous variant (-/-) 
genotype had a 2.2-fold increased risk of developing nasopharynx 
carcinoma (adjusted OR= 2.2; 95% CI= 1.02–2.54) compared with 
subjects with the wild-type and heterozygous (+/+and+/-) 
genotypes. The allele frequencies for the wild-type and variant 
form (+/+and-/-) of the CYP2E1 gene were found to be 0.77 and 
0.22 among the control population as; compared to 0.73 and 0.26 
within cancer cases, respectively. 
 
Table 2: Frequency distribution among case and control subjects and relative risk associated with genotypic variants of CYP2E1 detected 
by restriction enzyme digestion with Rsa I 
Frequency Case subjects 
(n = 100) 
Control subjects 
(n = 180) 
p OR (95% CI) 
CYP2E1 genotype     
Rsa I     
+/+ 58 (58.0)  108 (60.0)    [0.72-1.2] 0.96 
+/- 31 (31.0)  63 (35.0)    [0.66-1.09] 0.88 
-/- 11 (11.0)   9 (5.0)  <0.05  [1.02-2.54] 2.2 
Allele frequency     
+/+ 0.73 0.77   
-/ - 0.26 0.22   
+/+homozygote for the common allele; +/-, heterozygote; -/-homozygote for the variant allele.  
 
Results of the analysis of the interaction between smoking and CYP2E1 
polymorphisms on the risk of the cancer were also examined. Table 3 
shows the ORs of nasopharyngeal carcinoma related to CYP2E1 
genotypes by exposure to tobacco smoking. An excessive risk with 
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borderline significance (OR= 1.78; 95% CI= 0.98-2.9) was found to be 
related to smoking only among those with at least one copy variant 
allele (-/-) of the CYP2E1 compared with to nonsmokers. We observed 
a strong and statistically significant modification of the CYP2E1 effect 
by smoking status (table 3). Among smokers, individuals homozygous 
for the variant allele (-/-) of the CYP2E1 gene were at a 3.3-fold 
increased risk of disease relative to nonsmokers who were 
homozygous for the variant allele (-/-) of the CYP2E1 gene (OR= 
0.3; 95% CI =0.08-1.01). We also examined the effect of CYP2E1 
genotype separately for age (table 4). A stronger association between 
homozygosity for variant allele (-/-) of the CYP2E1 and 
nasopharyngeal carcinoma was observed among patients whose age is 
between 40 and 60 y (OR= 3.7; 95% CI= 1.78-5.96) compared with 
patients whose age is more than 60 y (OR= 1.92; 95% CI = 1.03-2.33). 
 
Table 3: Joint effect of CYP2E1 genotypic variants detected by Rsa I digestion and cigarette smoking on nasopharyngeal carcinoma risk 
Smoking +/+ +/- -/- 
No. of case/No. of 
control subjects 
OR (95% CI) No. of case/No. of 
control subjects 
OR (95% CI) No. of. case/No. of 
control subjects 
OR (95% CI) 
Smokers  30/36 [0.87-2.07] 1.14  24/25 [0.98-2.9] 1.78   8/4 [1.22-4.58]3.33  
Nonsmokers  28/72 [0.18-1.23] 0.46  7/38  0.09-1.13] 0.22   3/5 [0.08-1.01] 0.3 
+/+homozygote for the common allele; +/-, heterozygote; -/-homozygote for the variant allele. 
 
Table 4: Joint effect of CYP2E1 genotypic variants detected by Rsa I digestion and age on nasopharyngeal carcinoma risk 
Age/Year +/+ +/- -/- 
No. of case/No. of 
control subjects 
Or (95% CI) No. of case/No. of 
control subjects 
Or (95% CI) No. of. case/No. of 
control subjects 
Or (95% CI) 
20-40 11/15 [0.42-2.42] 1.03 5/16 [0.09-1.56]0.53  4/4 [1.12-3.69]1.89 
40-60 28/57 [0.32-2.09] 0.83 22/38 [0.39-2.34]1.05  4/2 [1.78-5.96] 3.7 
+60 19/36 [1.23-2.35] 0.93  4/9 [0.21-1.97] 0.79 3/3 [1.03-2.33] 1.92 
+/+homozygote for the common allele; +/-, heterozygote; -/-homozygote for the variant allele. 
 
DISCUSSION 
Epidemiological studies have shown that up to 90% of all cancers 
are related to environmental factors. Most of the environmental 
carcinogens need to be metabolically activated to exert their 
carcinogenic effects [20, 21]. Genetic polymorphisms in enzymes 
involved in carcinogen metabolism have shown to influence the 
susceptibility to cancer [22, 23]. Cytochrome P4502E1 (CYP2E1) 
plays an important role in this process. It participates in the 
metabolic activation of carcinogenic nitrosamines. Several recent 
studies show that the genetic polymorphisms of metabolizing 
enzymes are associated with some cancers such as lung cancer [24, 
25], nasopharyngeal cancer [25, 26] and colorectal cancer [27]. But 
the results of those studies of the relation between CYP2E1 and 
cancer susceptibility are inconsistent [28]. 
The possibility of making N-nitrosated compounds involved in NPC 
cancer has been an issue for many years. In this study, cigarette 
smoke was positively associated with NPC cancer [29, 30]. Tobacco 
smoke contains many potential carcinogens, also including nitroso 
compounds [31]. The results obtained from the current study 
confirm our previous data, suggesting an association between 
CYP2E1 genetic polymorphisms and risk of nasopharyngeal 
carcinoma. On the basis of this study of 100 patients diagnosed with 
nasopharyngeal carcinoma and 180 control subjects, the distribution 
of a homozygous variant form of the CYP2E1 gene much in different 
races. Frequencies of the variant allele (-/-) are: 4% in European-
Americans, 29.5% in Thailand, 18% in Taiwanese [19], 8% in China, 
and 1.94% in Turkish population.  
Our study finds that frequencies of the variant allele (-/-) are 26% in 
Algeria population, alike to the allele frequencies of Thailand, but 
not comparable to the North African population that could not be 
performed. In regards of a combination of these genotypes and risk 
of NPC, the overall risk of NPC was found to be 2.2 times higher in 
case of homozygous variant (-/-) state. Since CYP2E1 is involved in 
the metabolic activation of numerous procarcinogens [32], this 
observation is in agreement with recent studies showing that the 
homozygous variant (-/-) genotype of CYP2E1 was associated with 
increased risk of nasopharyngeal [33] in Tunisia, Caucasian, Asian 
[5] and Taiwan populations [34].  
In; contrary the results also exist reporting no association between 
CYP2E1 (-/-) genotype and cancers or reporting that excessive risk 
of certain types of cancer is associated with (+/+) variant genotype 
[21]. The reason for this discrepancy is not clear, but several 
possibilities, such as ethnic differences in allele frequencies and 
specific exposures associated with the polymorphism, should be 
considered [25].  
Several studies reported that homozygous variant form was 
associated with enhanced enzyme activity. Hayashi et al. [35] 
reported that enhanced activity of variant form DNA was about 10 
times than that of wild-type DNA. The variant allele (-/-) of the 
CYP2E1 affects the phenotype directly rather than being a 
consequence of linkage disequilibrium from another mutation or 
gene [35]. This difference in the transcriptional activities might 
associate with the susceptibility in human carcinogenesis.  
A higher level of expression in the variant form would result in 
larger amounts of procarcinogens being changed into carcinogens 
that then produce DNA damage.  
This result of genotype-phenotype relationship further supports our 
and others findings showing that the variant allele (-/-) of the 
CYP2E1 is a genetic susceptibility factor for certain types of 
exposures. We also found a significant association between the 
homozygous variant (-/-) genotype and age in our study, individuals 
in the 40–60 y age group showed a strong association in the CNP in 
the presence of the homozygous variant (-/-) genotype of the 
CYP2E1 (OR=3.7; 95% IC =1.78-5.96). This shows that an early 
exposure to tobacco would cause the expression of a number more 
important of cancer mutations. Such patients present factor genetic 
regulation of oncogenic expression. 
CONCLUSION 
In conclusion, our results demonstrate a significant association between 
CYP2E1 genetic Polymorphism and nasopharyngeal carcinoma risk. The 
association was restricted to smokers, genetic susceptibility factors for 
nasopharyngeal carcinoma identified in our study could serve as useful 
biomarkers for targeting prevention of cancer. 
ABBREVIATION 
CYP2E1-cytochrome P450 2E1, PCR-polymerase chain reaction, RFLP-
restriction fragment length polymorphism, CI-confidence interval, 
NPC-nasopharyngeal cancer, x2-pearson’s x2 test, OR-odds ratio.  
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